IL10 and melanoma: When the supernatant of this construct was added to a monocyte culture, increased levels of IL-10 could drive monocyte differentiation to tumor-associated M2-like macrophages, thus describing a novel mechanism of immune tolerance in melanoma [23] and a possible therapeutic target to overcome it.